MCCP
MRNA icon

Mission Creek Capital Partners’s Moderna MRNA Stock Holding History

Mission Creek Capital Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-92,017
Closed -$10.9M – 227
2024
Q2 		$10.9M Buy
92,017
+89,612
+3,726% +$11.3M 2.75% 4
2024
Q1 		$256K Buy
+2,405
New +$242K 0.07% 215
2020
Q1 		– Sell
-118,876
Closed -$2.33M – 178
2019
Q4 		$2.33M Buy
+118,876
New +$2.11M 1.06% 19

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mission Creek Capital Partners's MRNA Position: Q3 2024 in Review

Mission Creek Capital Partners sold out of Moderna (MRNA) in Q3 2024, closing a stake of 92,017 shares — an estimated $10.9M sold.

Mission Creek Capital Partners first reported a position in MRNA in Q4 2019 and held it in 3 quarters. The position peaked at $10.9M in Q2 2024. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Mission Creek Capital Partners reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Mission Creek Capital Partners sold 92,017 Moderna shares in Q3 2024, an estimated $10.9M.
  • Mission Creek Capital Partners first reported a position in Moderna in Q4 2019 and held it in 3 quarters.
  • Mission Creek Capital Partners's Moderna position peaked at $10.9M in Q2 2024.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Mission Creek Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.